TOCILIZUMAB
tocilizumab 400 mg/20 mL injection, 20 mL vial
TOCILIZUMAB (13338B)
13338B
Manner of administration:Injection
Restriction (Streamlined authority code: 17713)
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $424.25 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Actemra | |||||